Next Article in Journal
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles
Next Article in Special Issue
Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens
Previous Article in Journal
Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database
Previous Article in Special Issue
Strategies for Immunomonitoring after Vaccination and during Infection
 
 
Article

Article Versions Notes

Vaccines 2021, 9(4), 394; https://doi.org/10.3390/vaccines9040394
Action Date Notes Link
article xml file uploaded 16 April 2021 11:42 CEST Original file -
article xml uploaded. 16 April 2021 11:42 CEST Update -
article pdf uploaded. 16 April 2021 11:42 CEST Version of Record https://www.mdpi.com/2076-393X/9/4/394/pdf-vor
article html file updated 16 April 2021 11:43 CEST Original file -
article xml file uploaded 17 April 2021 08:12 CEST Update -
article xml uploaded. 17 April 2021 08:12 CEST Update https://www.mdpi.com/2076-393X/9/4/394/xml
article pdf uploaded. 17 April 2021 08:12 CEST Updated version of record https://www.mdpi.com/2076-393X/9/4/394/pdf
article html file updated 17 April 2021 08:14 CEST Update -
article html file updated 25 July 2022 12:30 CEST Update https://www.mdpi.com/2076-393X/9/4/394/html
Back to TopTop